These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 30850660)

  • 1. Targeting of dermal myofibroblasts through death receptor 5 arrests fibrosis in mouse models of scleroderma.
    Park JS; Oh Y; Park YJ; Park O; Yang H; Slania S; Hummers LK; Shah AA; An HT; Jang J; Horton MR; Shin J; Dietz HC; Song E; Na DH; Park EJ; Kim K; Lee KC; Roschke VV; Hanes J; Pomper MG; Lee S
    Nat Commun; 2019 Mar; 10(1):1128. PubMed ID: 30850660
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeted apoptosis of myofibroblasts with the BH3 mimetic ABT-263 reverses established fibrosis.
    Lagares D; Santos A; Grasberger PE; Liu F; Probst CK; Rahimi RA; Sakai N; Kuehl T; Ryan J; Bhola P; Montero J; Kapoor M; Baron M; Varelas X; Tschumperlin DJ; Letai A; Tager AM
    Sci Transl Med; 2017 Dec; 9(420):. PubMed ID: 29237758
    [TBL] [Abstract][Full Text] [Related]  

  • 3. alpha-melanocyte-stimulating hormone suppresses bleomycin-induced collagen synthesis and reduces tissue fibrosis in a mouse model of scleroderma: melanocortin peptides as a novel treatment strategy for scleroderma?
    Kokot A; Sindrilaru A; Schiller M; Sunderkötter C; Kerkhoff C; Eckes B; Scharffetter-Kochanek K; Luger TA; Böhm M
    Arthritis Rheum; 2009 Feb; 60(2):592-603. PubMed ID: 19180474
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interferon-γ Induces Interleukin-6 Production and Alpha-smooth Muscle Actin Expression in Systemic Sclerosis Fibroblasts.
    Rokni M; Farhadi E; Kavosi H; Akhtari M; Madreseh E; Enayati S; Sadeghi Shaker M; Mostafaei S; Gharibdoost F; Mahmoudi M; Vodjgani M
    Iran J Allergy Asthma Immunol; 2024 Apr; 23(2):197-220. PubMed ID: 38822514
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tropisetron suppresses collagen synthesis in skin fibroblasts via α7 nicotinic acetylcholine receptor and attenuates fibrosis in a scleroderma mouse model.
    Stegemann A; Sindrilaru A; Eckes B; del Rey A; Heinick A; Schulte JS; Müller FU; Grando SA; Fiebich BL; Scharffetter-Kochanek K; Luger TA; Böhm M
    Arthritis Rheum; 2013 Mar; 65(3):792-804. PubMed ID: 23440693
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of selexipag and its active metabolite in contrasting the profibrotic myofibroblast activity in cultured scleroderma skin fibroblasts.
    Cutolo M; Ruaro B; Montagna P; Brizzolara R; Stratta E; Trombetta AC; Scabini S; Tavilla PP; Parodi A; Corallo C; Giordano N; Paolino S; Pizzorni C; Sulli A; Smith V; Soldano S
    Arthritis Res Ther; 2018 May; 20(1):77. PubMed ID: 29720235
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Periostin facilitates skin sclerosis via PI3K/Akt dependent mechanism in a mouse model of scleroderma.
    Yang L; Serada S; Fujimoto M; Terao M; Kotobuki Y; Kitaba S; Matsui S; Kudo A; Naka T; Murota H; Katayama I
    PLoS One; 2012; 7(7):e41994. PubMed ID: 22911870
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Canonical Wnt signaling induces skin fibrosis and subcutaneous lipoatrophy: a novel mouse model for scleroderma?
    Wei J; Melichian D; Komura K; Hinchcliff M; Lam AP; Lafyatis R; Gottardi CJ; MacDougald OA; Varga J
    Arthritis Rheum; 2011 Jun; 63(6):1707-17. PubMed ID: 21370225
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Disruption of transforming growth factor beta signaling and profibrotic responses in normal skin fibroblasts by peroxisome proliferator-activated receptor gamma.
    Ghosh AK; Bhattacharyya S; Lakos G; Chen SJ; Mori Y; Varga J
    Arthritis Rheum; 2004 Apr; 50(4):1305-18. PubMed ID: 15077315
    [TBL] [Abstract][Full Text] [Related]  

  • 10. RNA interference against platelet-derived growth factor receptor α mRNA inhibits fibroblast transdifferentiation in skin lesions of patients with systemic sclerosis.
    Liu T; Zhang J; Zhang J; Mu X; Su H; Hu X; Liu W; Zhao E; Li W
    PLoS One; 2013; 8(4):e60414. PubMed ID: 23577108
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 5-HT
    Chaturvedi S; Misra DP; Prasad N; Rastogi K; Singh H; Rai MK; Agarwal V
    Int J Rheum Dis; 2018 Dec; 21(12):2128-2138. PubMed ID: 30207074
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Transdifferentiation of fibroblasts into myofibroblasts in the skin lesion of systemic sclerosis: role of transforming growth factor β1 and its signal transduction].
    Liu T; Hu XD
    Nan Fang Yi Ke Da Xue Xue Bao; 2011 Nov; 31(11):1840-5. PubMed ID: 22126761
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inactivation of urokinase-type plasminogen activator receptor (uPAR) gene induces dermal and pulmonary fibrosis and peripheral microvasculopathy in mice: a new model of experimental scleroderma?
    Manetti M; Rosa I; Milia AF; Guiducci S; Carmeliet P; Ibba-Manneschi L; Matucci-Cerinic M
    Ann Rheum Dis; 2014 Sep; 73(9):1700-9. PubMed ID: 23852693
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Echinochrome A Treatment Alleviates Fibrosis and Inflammation in Bleomycin-Induced Scleroderma.
    Park GT; Yoon JW; Yoo SB; Song YC; Song P; Kim HK; Han J; Bae SJ; Ha KT; Mishchenko NP; Fedoreyev SA; Stonik VA; Kim MB; Kim JH
    Mar Drugs; 2021 Apr; 19(5):. PubMed ID: 33922418
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Human Skin Model Recapitulates Systemic Sclerosis Dermal Fibrosis and Identifies COL22A1 as a TGFβ Early Response Gene that Mediates Fibroblast to Myofibroblast Transition.
    Watanabe T; Baker Frost DA; Mlakar L; Heywood J; da Silveira WA; Hardiman G; Feghali-Bostwick C
    Genes (Basel); 2019 Jan; 10(2):. PubMed ID: 30678304
    [No Abstract]   [Full Text] [Related]  

  • 16. Targeting of NADPH oxidase in vitro and in vivo suppresses fibroblast activation and experimental skin fibrosis.
    Dosoki H; Stegemann A; Taha M; Schnittler H; Luger TA; Schröder K; Distler JH; Kerkhoff C; Böhm M
    Exp Dermatol; 2017 Jan; 26(1):73-81. PubMed ID: 27576129
    [TBL] [Abstract][Full Text] [Related]  

  • 17. miRNA-29a in systemic sclerosis: A valid target.
    O'Reilly S
    Autoimmunity; 2015; 48(8):511-2. PubMed ID: 26335042
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting the myofibroblast genetic switch: inhibitors of myocardin-related transcription factor/serum response factor-regulated gene transcription prevent fibrosis in a murine model of skin injury.
    Haak AJ; Tsou PS; Amin MA; Ruth JH; Campbell P; Fox DA; Khanna D; Larsen SD; Neubig RR
    J Pharmacol Exp Ther; 2014 Jun; 349(3):480-6. PubMed ID: 24706986
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dabigatran, a direct thrombin inhibitor, demonstrates antifibrotic effects on lung fibroblasts.
    Bogatkevich GS; Ludwicka-Bradley A; Silver RM
    Arthritis Rheum; 2009 Nov; 60(11):3455-64. PubMed ID: 19877031
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Animal model of sclerotic skin. V: Increased expression of alpha-smooth muscle actin in fibroblastic cells in bleomycin-induced scleroderma.
    Yamamoto T; Nishioka K
    Clin Immunol; 2002 Jan; 102(1):77-83. PubMed ID: 11781070
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.